Christine Siu
CIK 1743029 · CFO and Secretary · last filed 2025-06-16
Christine Siu is a CFO and Secretary who has filed 14 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for GLUE, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$4.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
14
-$4.77M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GLUE | Director | — | $18.23 | — | $0 | 5 | 2025-06-16 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | CFO and Secretary | 46,470 | — | — | -$4.77M | 9 | 2019-12-11 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2021-06-25 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | Eidos Therapeutics, Inc. (EIDX) Delisted | Mixed | — | -$590.7K | EDGAR |
| 2019-12-05 | Eidos Therapeutics, Inc. (EIDX) Delisted | Mixed | — | -$1.17M | EDGAR |
| 2019-11-22 | Eidos Therapeutics, Inc. (EIDX) Delisted | Mixed | — | -$1.90M | EDGAR |
| 2019-07-12 | Eidos Therapeutics, Inc. (EIDX) Delisted | Mixed | — | -$193.9K | EDGAR |
| 2019-06-28 | Eidos Therapeutics, Inc. (EIDX) Delisted | Exer (M) | +17,000 | $10.0K | EDGAR |